Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 9, 2001

View Archived Issues

AxyS describes new serine protease inhibitor design technology

Ascorbic acid enhances arsenic trioxide potency in MM cells

Replagal receives European approval for Fabry's disease

Graffinity Pharmaceutical Design and Biosearch Italia form drug discovery alliance

Data from Metformin GR phase II trial reported by DepoMed

Lexicon Genetics and Immunex enter drug target validation agreement

Novel imino sugar inhibits HBV DNA replication without affecting DNA polymerase function

Lorus Therapeutics expands Virulizin clinical trial for pancreatic cancer

MedImmune begins Vitaxin phase I trials for rheumatoid arthritis

Guanfacine improves tic disorders and ADHD in children

Baxter to acquire Asta Medica Oncology

Bayer withdraws cerivastatin worldwide

FDA approves PEG-Intron for use with Rebetol

Trimeris and Array Biopharma sign drug discovery agreement

Sustained-release preparations of hypoglycemic drugs described by Ajinomoto

BVdU reported to be useful for inhibiting the growth of hyperproliferative cells

Cyclin-dependent kinase inhibitors identified by Bristol-Myers Squibb

Kyowa Hakko patents new compounds for treatment of urinary incontinence

Smooth muscle-relaxing agents reported by Kissei

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...